Devex: Q&A: Why the U.S. should invest in global health innovation — for its own sake
“…[A global health event on Thursday] was organized by the Global Health Technologies Coalition, 25 nonprofit organizations advocating for research and development for new drugs, vaccines, diagnostics, and other global health technologies to coincide with the release of a report called ‘Return on innovation: Why global health R&D is a smart investment for the United States.’ Following the event, Devex spoke with Jamie Bay Nishi, director of GHTC, about takeaways from the report and how they will inform the organization’s advocacy efforts…” (Cheney, 7/21).